BRPI0716549A2 - moduladores de quinase associada de interleucina-1 - Google Patents
moduladores de quinase associada de interleucina-1Info
- Publication number
- BRPI0716549A2 BRPI0716549A2 BRPI0716549-8A2A BRPI0716549A BRPI0716549A2 BR PI0716549 A2 BRPI0716549 A2 BR PI0716549A2 BR PI0716549 A BRPI0716549 A BR PI0716549A BR PI0716549 A2 BRPI0716549 A2 BR PI0716549A2
- Authority
- BR
- Brazil
- Prior art keywords
- interleukin
- associated kinase
- kinase modulators
- modulators
- kinase
- Prior art date
Links
- 102000000589 Interleukin-1 Human genes 0.000 title 1
- 108010002352 Interleukin-1 Proteins 0.000 title 1
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84280106P | 2006-09-07 | 2006-09-07 | |
| PCT/US2007/019588 WO2008030584A2 (en) | 2006-09-07 | 2007-09-07 | Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0716549A2 true BRPI0716549A2 (pt) | 2013-09-24 |
Family
ID=39157878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0716549-8A2A BRPI0716549A2 (pt) | 2006-09-07 | 2007-09-07 | moduladores de quinase associada de interleucina-1 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8293923B2 (pt) |
| EP (1) | EP2061786A2 (pt) |
| JP (1) | JP2010502717A (pt) |
| KR (1) | KR20090049076A (pt) |
| CN (1) | CN101616910A (pt) |
| AU (1) | AU2007292929A1 (pt) |
| BR (1) | BRPI0716549A2 (pt) |
| CA (1) | CA2663100A1 (pt) |
| IL (1) | IL197274A0 (pt) |
| MX (1) | MX2009002377A (pt) |
| NO (1) | NO20091326L (pt) |
| NZ (1) | NZ575410A (pt) |
| RU (1) | RU2459821C2 (pt) |
| WO (1) | WO2008030584A2 (pt) |
| ZA (1) | ZA200901529B (pt) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2243481A1 (en) * | 2009-04-24 | 2010-10-27 | PamGene B.V. | Irak kinase family as novel drug target for Alzheimer |
| ES2672203T3 (es) * | 2010-11-19 | 2018-06-13 | Ligand Pharmaceuticals Inc. | Aminas heterocíclicas y usos de las mismas |
| EP2858500A4 (en) | 2012-06-08 | 2016-04-06 | Biogen Ma Inc | BRUTON TYROSINE KINASE HEMMER |
| US9586948B2 (en) | 2012-10-08 | 2017-03-07 | Merck Sharp & Dohme Corp. | Inhibitors of IRAK4 activity |
| US9598440B2 (en) | 2012-10-08 | 2017-03-21 | Merck Sharp & Dohme Corp. | Inhibitors of IRAK4 activity |
| EP2746259A1 (en) | 2012-12-21 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
| EP2746260A1 (en) | 2012-12-21 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
| PL2953944T3 (pl) * | 2013-02-07 | 2017-09-29 | Merck Patent Gmbh | Pochodne pirydazynonowe-amidowe |
| US9550794B2 (en) * | 2013-02-07 | 2017-01-24 | Merck Patent Gmbh | Macrocyclic pyridazinone derivatives |
| EP3019171B1 (en) | 2013-07-11 | 2018-09-05 | Merck Sharp & Dohme Corp. | Substituted amidopyrazole inhibitors of interleukin receptor-associated kinases (irak-4) |
| TWI667233B (zh) * | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
| CA2935880A1 (en) * | 2014-01-10 | 2015-07-16 | Aurigene Discovery Technologies Limited | Indazole compounds as irak4 inhibitors |
| US9732095B2 (en) * | 2014-01-13 | 2017-08-15 | Aurigene Discovery Technologies Limited | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors |
| MX2016017147A (es) * | 2014-06-20 | 2017-06-07 | Aurigene Discovery Tech Ltd | Compuestos de indazole substituidos como inhibidores de irak4. |
| JO3705B1 (ar) * | 2014-11-26 | 2021-01-31 | Bayer Pharma AG | إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية |
| TW201702218A (zh) | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法 |
| US10807983B2 (en) | 2015-03-16 | 2020-10-20 | Ligand Pharmaceuticals, Inc. | Imidazo-fused heterocycles and uses thereof |
| EP3195865A1 (de) | 2016-01-25 | 2017-07-26 | Bayer Pharma Aktiengesellschaft | Kombinationen von irak4 inhibitoren und btk inhibitoren |
| CA2984259C (en) | 2015-04-30 | 2024-02-13 | Bayer Pharma Aktiengesellschaft | Combinations of inhibitors of irak4 with inhibitors of btk |
| EP3423446B1 (de) | 2016-03-03 | 2020-09-16 | Bayer Pharma Aktiengesellschaft | Neue 2-substituierte indazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| EP3219329A1 (en) | 2016-03-17 | 2017-09-20 | Bayer Pharma Aktiengesellschaft | Combinations of copanlisib |
| DK3448849T3 (da) | 2016-04-29 | 2020-06-29 | Bayer Pharma AG | Syntese af indazoler |
| WO2017186689A1 (en) | 2016-04-29 | 2017-11-02 | Bayer Pharma Aktiengesellschaft | Synthesis of indazoles |
| ES2898771T3 (es) | 2016-06-01 | 2022-03-08 | Bayer Animal Health Gmbh | Indazoles sustituidos útiles para el tratamiento y la prevención de enfermedades alérgicas y/o inflamatorias en animales |
| CN106222183B (zh) * | 2016-07-25 | 2019-11-08 | 南通大学 | 靶向人irak1基因的小干扰rna及其应用 |
| JOP20180011A1 (ar) | 2017-02-16 | 2019-01-30 | Gilead Sciences Inc | مشتقات بيرولو [1، 2-b]بيريدازين |
| AU2018242623B2 (en) | 2017-03-31 | 2024-05-02 | Aurigene Oncology Limited | Compounds and compositions for treating hematological disorders |
| CN111194319A (zh) | 2017-10-19 | 2020-05-22 | 拜耳动物保健有限责任公司 | 稠合的杂芳族吡咯烷酮类化合物用于治疗和预防动物中的疾病的用途 |
| CN111225911B (zh) | 2017-10-31 | 2023-09-01 | 库里斯公司 | 用于治疗血液病的化合物和组合物 |
| WO2019111218A1 (en) | 2017-12-08 | 2019-06-13 | Cadila Healthcare Limited | Novel heterocyclic compounds as irak4 inhibitors |
| TWI721483B (zh) | 2018-07-13 | 2021-03-11 | 美商基利科學股份有限公司 | 吡咯并[1,2-b]嗒𠯤衍生物 |
| CR20220036A (es) * | 2019-06-27 | 2022-05-04 | Biogen Ma Inc | Derivados de 2h-indazol y su uso en el tratamiento de enfermedades |
| CA3181537A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| US12043632B2 (en) | 2020-12-23 | 2024-07-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
| MX2023011790A (es) | 2021-04-08 | 2023-10-11 | Curis Inc | Terapias combinadas para tratar el cancer. |
| CN115710253B (zh) * | 2021-08-23 | 2024-07-02 | 上海交通大学 | 一类含有氨基苯并咪唑类衍生物及其制备和用途 |
| JP2024540292A (ja) | 2021-11-09 | 2024-10-31 | エイジャックス セラピューティクス， インコーポレイテッド | Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8716111D0 (en) * | 1987-07-08 | 1987-08-12 | Unilever Plc | Edible plastic dispersion |
| CN1114604C (zh) * | 1996-11-15 | 2003-07-16 | 达尔文发现有限公司 | 双环芳基甲酰胺及其治疗应用 |
| CA2282593A1 (en) * | 1997-03-31 | 1998-10-08 | Du Pont Pharmaceuticals Company | Indazoles of cyclic ureas useful as hiv protease inhibitors |
| AU769350B2 (en) * | 1999-06-23 | 2004-01-22 | Sanofi-Aventis Deutschland Gmbh | Substituted benzimidazole |
| AU2002332099B2 (en) | 2001-10-09 | 2007-12-13 | Amgen Inc. | Imidazole derivates as antiinflammatory agents |
| EP1499311B1 (en) * | 2002-03-29 | 2009-11-04 | Novartis Vaccines and Diagnostics, Inc. | Substituted benzazoles and use thereof as raf kinase inhibitors |
-
2007
- 2007-09-07 AU AU2007292929A patent/AU2007292929A1/en not_active Abandoned
- 2007-09-07 EP EP07837920A patent/EP2061786A2/en not_active Withdrawn
- 2007-09-07 RU RU2009112598/04A patent/RU2459821C2/ru not_active IP Right Cessation
- 2007-09-07 MX MX2009002377A patent/MX2009002377A/es not_active Application Discontinuation
- 2007-09-07 US US12/440,163 patent/US8293923B2/en not_active Expired - Fee Related
- 2007-09-07 JP JP2009527438A patent/JP2010502717A/ja active Pending
- 2007-09-07 KR KR1020097006123A patent/KR20090049076A/ko not_active Ceased
- 2007-09-07 BR BRPI0716549-8A2A patent/BRPI0716549A2/pt not_active IP Right Cessation
- 2007-09-07 WO PCT/US2007/019588 patent/WO2008030584A2/en active Application Filing
- 2007-09-07 CA CA002663100A patent/CA2663100A1/en not_active Abandoned
- 2007-09-07 CN CN200780041379A patent/CN101616910A/zh active Pending
- 2007-09-07 NZ NZ575410A patent/NZ575410A/en not_active IP Right Cessation
-
2009
- 2009-02-26 IL IL197274A patent/IL197274A0/en unknown
- 2009-03-03 ZA ZA200901529A patent/ZA200901529B/xx unknown
- 2009-04-01 NO NO20091326A patent/NO20091326L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2009112598A (ru) | 2010-10-20 |
| IL197274A0 (en) | 2009-12-24 |
| ZA200901529B (en) | 2009-11-25 |
| JP2010502717A (ja) | 2010-01-28 |
| RU2459821C2 (ru) | 2012-08-27 |
| CA2663100A1 (en) | 2008-03-13 |
| KR20090049076A (ko) | 2009-05-15 |
| NO20091326L (no) | 2009-04-01 |
| NZ575410A (en) | 2012-03-30 |
| WO2008030584A3 (en) | 2008-07-17 |
| US8293923B2 (en) | 2012-10-23 |
| MX2009002377A (es) | 2009-03-13 |
| CN101616910A (zh) | 2009-12-30 |
| US20110152260A1 (en) | 2011-06-23 |
| EP2061786A2 (en) | 2009-05-27 |
| WO2008030584A2 (en) | 2008-03-13 |
| AU2007292929A1 (en) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0716549A2 (pt) | moduladores de quinase associada de interleucina-1 | |
| BRPI0717035A2 (pt) | Moduladores de benzotriazol cinase | |
| EP2059391A4 (en) | MATRICES DOPED BY NANOCRYSTALS | |
| CR10841A (es) | Imidazotriazinas imidazopirimidinas inhibidores de cinasa | |
| EP2089308A4 (en) | DONOR | |
| DE602006004717D1 (de) | Kapselperforationsmodul | |
| DE602007002544D1 (de) | Nuancierungsmittel | |
| DE112007002915A5 (de) | Verstelleinrichtung | |
| DE602007003893D1 (de) | Kippambossanordnung | |
| DE602007006947D1 (de) | Pyridopyrimidinonderivate | |
| DE602006020192D1 (de) | Riemenscheibenanorndung | |
| DE602007000258D1 (de) | Kassetteneinspannmechanismus | |
| DE602007001280D1 (de) | Getränkeextraktor | |
| AT504580A3 (de) | Scan-einrichtung | |
| DE602006019150D1 (de) | Riemenscheibenanorndung | |
| ATE546437T1 (de) | Aminomethyl-4-imidazole | |
| DE502007000218D1 (de) | nsetzungen | |
| DE502007001629D1 (de) | Rfahren | |
| DE602007000501D1 (de) | Breitbandrichtkoppler | |
| DE502007002453D1 (de) | Kunstoffverdichtergehäuse | |
| DE602007004080D1 (de) | Tintenstrahlaufnehmer | |
| DE602007007460D1 (de) | Sehkrafttestsystem | |
| DE602006016174D1 (de) | Blisterverpackungsverfahren | |
| DE502007000361D1 (de) | Stanznieteinheit | |
| DE602007001098D1 (de) | Spindelmäheinheit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2277 DE 26/08/2014. |